Cargando…
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Epstein–Barr virus (EBV) is a human tumor virus and a model of herpesviral latency. The virus efficiently infects resting human B lymphocytes and induces their continuous proliferation in vitro, which mimics certain aspects of EBV’s oncogenic potential in vivo. How lymphoblastoid cell lines (LCLs) e...
Autores principales: | Mrozek-Gorska, Paulina, Buschle, Alexander, Pich, Dagmar, Schwarzmayr, Thomas, Fechtner, Ron, Scialdone, Antonio, Hammerschmidt, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690029/ https://www.ncbi.nlm.nih.gov/pubmed/31341086 http://dx.doi.org/10.1073/pnas.1901314116 |
Ejemplares similares
-
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
por: Pich, Dagmar, et al.
Publicado: (2019) -
Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
por: Lam, W. K. Jacky, et al.
Publicado: (2018) -
Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
por: Buschle, Alexander, et al.
Publicado: (2021) -
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
por: Kashyap, Abhishek S., et al.
Publicado: (2020) -
Ribosome collisions alter frameshifting at translational reprogramming motifs in bacterial mRNAs
por: Smith, Angela M., et al.
Publicado: (2019)